2021
DOI: 10.2169/internalmedicine.6694-20
|View full text |Cite
|
Sign up to set email alerts
|

Progressive Massive Splenomegaly in an Adult Patient with Kabuki Syndrome Complicated with Immune Thrombocytopenic Purpura

Abstract: Kabuki syndrome is characterized by multiple systemic anomalies and intellectual disability. It is complicated with immunodeficiencies and autoimmune disorders. The syndrome is caused by a mutation in the KMT2D gene. We herein report a case of a Kabuki syndrome with developing immune thrombocytopenic purpura (ITP) and progressive splenomegaly. Laparoscopic splenectomy was performed and the patients' symptoms quickly disappeared with platelet recovery. After this operation, the patient had no severe complicatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Since its introduction to the medical literature, hundreds of patients with Kabuki syndrome have been described. The majority of these patients are children, with rare case reports of patients in their 20s and 30s (Gooch et al, 2022; Hamahata et al, 2013; Mushino et al, 2021; Oto et al, 2008; Shalev et al, 2004). There is one piece describing long‐term follow‐up for three patients with a clinical diagnosis of Kabuki syndrome, but the reported patients were still only in their 20s at age of last follow up (Shalev et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Since its introduction to the medical literature, hundreds of patients with Kabuki syndrome have been described. The majority of these patients are children, with rare case reports of patients in their 20s and 30s (Gooch et al, 2022; Hamahata et al, 2013; Mushino et al, 2021; Oto et al, 2008; Shalev et al, 2004). There is one piece describing long‐term follow‐up for three patients with a clinical diagnosis of Kabuki syndrome, but the reported patients were still only in their 20s at age of last follow up (Shalev et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in KMT2D can disrupt terminal B-cell differentiation, leading to humoral immunodeficiency and autoimmunity. 13,14 KS patients with truncating-type KMT2D mutations often present with more typical and severe symptoms. 2 Thus, KMT2D mutation identification is crucial for predicting disease severity and autoimmune complications.…”
mentioning
confidence: 99%